Published in 2009, Tschp and DiMarchi's results provided the first demonstration that dual agonist drugs had potential to induce weight loss (Day, Ottaway, Patterson)
If you miss two or more consecutive days, you may notice a temporary return of appetite and food noise
For example, when looking at GLP-1 users who just started in the last 1-3 months, GLP-1 weight loss users spent 22% more (compared to the same 13-week period a year ago), while diabetes users spent slightly less
Healthcare professionals closely monitor such patients to minimize the risk of side effects and ensure optimal diabetes care
And whats been interesting about it for me, and I think this sort of leads into my next question about do we do this forever
If your prescriber gives you the medication and says "come back in three months," that is inadequate follow-up for a medication that requires titration and monitoring